BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 12208848)

  • 21. Notch signaling is a direct determinant of keratinocyte growth arrest and entry into differentiation.
    Rangarajan A; Talora C; Okuyama R; Nicolas M; Mammucari C; Oh H; Aster JC; Krishna S; Metzger D; Chambon P; Miele L; Aguet M; Radtke F; Dotto GP
    EMBO J; 2001 Jul; 20(13):3427-36. PubMed ID: 11432830
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circulating human papillomavirus type 16 specific T-cells are associated with HLA Class I expression on tumor cells, but not related to the amount of viral oncogene transcripts.
    de Boer MA; Jordanova ES; van Poelgeest MI; van den Akker BE; van der Burg SH; Kenter GG; Fleuren GJ
    Int J Cancer; 2007 Dec; 121(12):2711-5. PubMed ID: 17724722
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes.
    Li JJ; Rhim JS; Schlegel R; Vousden KH; Colburn NH
    Oncogene; 1998 May; 16(21):2711-21. PubMed ID: 9652737
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNA-18a targeting of the STK4/MST1 tumour suppressor is necessary for transformation in HPV positive cervical cancer.
    Morgan EL; Patterson MR; Ryder EL; Lee SY; Wasson CW; Harper KL; Li Y; Griffin S; Blair GE; Whitehouse A; Macdonald A
    PLoS Pathog; 2020 Jun; 16(6):e1008624. PubMed ID: 32555725
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of BPV1 E2-mediated inhibition of E6/E7 expression in HPV16-positive cervical carcinoma cells.
    Moon MS; Lee CJ; Um SJ; Park JS; Yang JM; Hwang ES
    Gynecol Oncol; 2001 Feb; 80(2):168-75. PubMed ID: 11161855
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Papillomavirus type 16 oncogenes downregulate expression of interferon-responsive genes and upregulate proliferation-associated and NF-kappaB-responsive genes in cervical keratinocytes.
    Nees M; Geoghegan JM; Hyman T; Frank S; Miller L; Woodworth CD
    J Virol; 2001 May; 75(9):4283-96. PubMed ID: 11287578
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantitation of human papillomavirus 16 E6 and E7 DNA and RNA in residual material from ThinPrep Papanicolaou tests using real-time polymerase chain reaction analysis.
    Wang-Johanning F; Lu DW; Wang Y; Johnson MR; Johanning GL
    Cancer; 2002 Apr; 94(8):2199-210. PubMed ID: 12001118
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MAML1 regulates cell viability via the NF-κB pathway in cervical cancer cell lines.
    Kuncharin Y; Sangphech N; Kueanjinda P; Bhattarakosol P; Palaga T
    Exp Cell Res; 2011 Aug; 317(13):1830-40. PubMed ID: 21640102
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tanshinone IIA inhibits viral oncogene expression leading to apoptosis and inhibition of cervical cancer.
    Munagala R; Aqil F; Jeyabalan J; Gupta RC
    Cancer Lett; 2015 Jan; 356(2 Pt B):536-46. PubMed ID: 25304375
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transcriptome signature of irreversible senescence in human papillomavirus-positive cervical cancer cells.
    Wells SI; Aronow BJ; Wise TM; Williams SS; Couget JA; Howley PM
    Proc Natl Acad Sci U S A; 2003 Jun; 100(12):7093-8. PubMed ID: 12756294
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Constitutive activation of transcription factor AP-1 in cervical cancer and suppression of human papillomavirus (HPV) transcription and AP-1 activity in HeLa cells by curcumin.
    Prusty BK; Das BC
    Int J Cancer; 2005 Mar; 113(6):951-60. PubMed ID: 15514944
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Physical status and expression of HPV genes in cervical cancers.
    Park JS; Hwang ES; Park SN; Ahn HK; Um SJ; Kim CJ; Kim SJ; Namkoong SE
    Gynecol Oncol; 1997 Apr; 65(1):121-9. PubMed ID: 9103401
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The presence of human papillomavirus-16/-18 E6, p53, and Bcl-2 protein in cervicovaginal smears from patients with invasive cervical cancer.
    Pillai MR; Halabi S; McKalip A; Jayaprakash PG; Rajalekshmi TN; Nair MK; Herman B
    Cancer Epidemiol Biomarkers Prev; 1996 May; 5(5):329-35. PubMed ID: 9162297
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human papillomavirus type 16 E6 amino acid 83 variants enhance E6-mediated MAPK signaling and differentially regulate tumorigenesis by notch signaling and oncogenic Ras.
    Chakrabarti O; Veeraraghavalu K; Tergaonkar V; Liu Y; Androphy EJ; Stanley MA; Krishna S
    J Virol; 2004 Jun; 78(11):5934-45. PubMed ID: 15140991
    [TBL] [Abstract][Full Text] [Related]  

  • 35. c-Myc substitutes for Notch1-CBF1 functions in cooperative transformation with papillomavirus oncogenes.
    Subramanyam D; Krishna S
    Virology; 2006 Mar; 347(1):191-8. PubMed ID: 16378632
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of HPV oncoproteins and cellular factors in maintenance of hTERT expression in cervical carcinoma cells.
    Jeong Seo E; Jung Kim H; Jae Lee C; Tae Kang H; Seong Hwang E
    Gynecol Oncol; 2004 Jul; 94(1):40-7. PubMed ID: 15262117
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Delta-Like Ligand-Notch1 Signaling Is Selectively Modulated by HPV16 E6 to Promote Squamous Cell Proliferation and Correlates with Cervical Cancer Prognosis.
    Khelil M; Griffin H; Bleeker MCG; Steenbergen RDM; Zheng K; Saunders-Wood T; Samuels S; Rotman J; Vos W; van den Akker BE; de Menezes RX; Kenter GG; Doorbar J; Jordanova ES
    Cancer Res; 2021 Apr; 81(7):1909-1921. PubMed ID: 33500246
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro antigene therapy targeting HPV-16 E6 and E7 in cervical carcinoma.
    Madrigal M; Janicek MF; Sevin BU; Perras J; Estape R; Peñalver M; Averette HE
    Gynecol Oncol; 1997 Jan; 64(1):18-25. PubMed ID: 8995542
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Complementation of human papillomavirus type 16 E6 and E7 by Jagged1-specific Notch1-phosphatidylinositol 3-kinase signaling involves pleiotropic oncogenic functions independent of CBF1;Su(H);Lag-1 activation.
    Veeraraghavalu K; Subbaiah VK; Srivastava S; Chakrabarti O; Syal R; Krishna S
    J Virol; 2005 Jun; 79(12):7889-98. PubMed ID: 15919944
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Suppression of HPV E6 and E7 expression by BAF53 depletion in cervical cancer cells.
    Lee K; Lee AY; Kwon YK; Kwon H
    Biochem Biophys Res Commun; 2011 Aug; 412(2):328-33. PubMed ID: 21821000
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.